Beta Bionics Announces Closing of $57 Million Series C Financing
![](http://startup-investment-review.com/wp-content/uploads/2022/02/betabionics-1024x535.jpg)
Beta Bionics, Inc. — a clinical stage medical technology company committed to the design, development, and commercialization of the iLet® Bionic Pancreas System — today announced the completion of a $57 million Series C equity financing. Proceeds from the financing will support product development, regulatory submissions, and preparations for the commercialization of the insulin dosing […]
Equip Raises $58 Million Series B Funding Round to Revolutionize Eating Disorder Treatment
![](http://startup-investment-review.com/wp-content/uploads/2022/02/treatment-eating-disorders.jpg)
Equip, the leading provider of virtual, evidence-based eating disorder treatment in the U.S., today announced a $58M Series B funding round, bringing the company’s total funding to $75M. The Chernin Group (TCG), an early investor in Headspace, led the round and was joined by Tiger Global and General Catalyst, as well as existing investors F-Prime […]